Skip to content
Screener

Karyopharm Therapeutics KPTI Q3 2025 earnings

Reported November 3, 2025 · Before market open

Revenue$44.0MBeat by $2.0M
EPS-$3.82Miss by $0.35
Revenue estimate$42.1M
EPS estimate-$3.47

Next report

Nov 2, 2026 (in a month)
Revenue estimate$33.5M
EPS estimate-$1.16

FAQ

When did Karyopharm Therapeutics report Q3 2025 earnings?
Karyopharm Therapeutics (KPTI) reported Q3 2025 earnings on November 3, 2025 before market open.
What were Karyopharm Therapeutics's Q3 2025 revenue and EPS?
Karyopharm Therapeutics reported revenue of $44.0M and eps of $-3.82 for Q3 2025.
Did Karyopharm Therapeutics beat estimates in Q3 2025?
Revenue beat the consensus estimate of $42.1M by $2.0M. EPS missed the consensus estimate of $-3.47 by $0.35.
How did Karyopharm Therapeutics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 13.6% from $38.8M a year earlier and eps grew 2.1% from $-3.90.
Where can I find Karyopharm Therapeutics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-261663) and the 10-Q periodic report (0001193125-25-261667) directly on SEC EDGAR. The filing index links above go to sec.gov.